tag:typepad.com,2003:weblog-537311 2013-05-22T12:40:45-04:00 The Latest News In Medical Devices and Diagnostics. From Elsevier Business Intelligence, Windhover Information and Medtech Insight - The ULTIMATE free weekly device e-newsletter. TypePad tag:typepad.com,2003:post-6a00d83452f00669e201901c74bcc7970b 2013-05-22T12:40:45-04:00 2013-05-22T12:41:26-04:00

Emerging technologies in peripheral nerve stimulation are expected to play a pivotal role in opening up new markets and driving growth in the neuromodulation device market in the years ahead. As a result, the pipeline is rich with products designed to address a growing number of patients with long-term pain and other chronic conditions, many of whom have no other treatment options.

Josh tag:typepad.com,2003:post-6a00d83452f00669e20192aa32f2cf970d 2013-05-22T12:30:51-04:00 2013-05-22T12:44:56-04:00

Women trying to get pregnant are seeking personalized, accurate, actionable information about fertility, and health IT and medtech start-ups are answering this need via the power of data. Profiles of Fertility Focus, OvuLine, and Univfy.

Josh tag:typepad.com,2003:post-6a00d83452f00669e201901c749f40970b 2013-05-22T12:23:39-04:00 2013-05-22T12:24:17-04:00

Covidien President and CEO Joe Almeida is positioning the company to continue its dynamic growth. Having run up an impressive track record over the past several years, where will – where can-- Covidien go from here?

Josh tag:typepad.com,2003:post-6a00d83452f00669e201901c6264b5970b 2013-05-20T12:32:35-04:00 2013-05-20T12:33:22-04:00

In addition to the more than 1,300 ablation procedures completed outside the U.S. with the unique visually guided ablation catheter, the venture-backed company is conducting an IDE trial in 21 U.S. centers, which it expects to complete in 2014.

Josh tag:typepad.com,2003:post-6a00d83452f00669e20191022d8af4970c 2013-05-15T17:43:25-04:00 2013-05-15T17:43:25-04:00

Recent progress on the US regulatory front is generating renewed interest in device-based glaucoma therapies, which potentially could grow to a multibillion-dollar industry. The list of companies targeting this space continues to expand, as does the variety of potential device-based solutions: the current pipeline includes several innovative and less invasive products and technologies designed to improve surgical outcomes, a growing number of advanced drug-delivery inserts to address the patient noncompliance issue that is so common in this arena, and some unique patient monitoring devices.

Josh tag:typepad.com,2003:post-6a00d83452f00669e2017eeb34e24f970d 2013-05-15T17:39:31-04:00 2013-05-15T17:39:31-04:00

Fertility Focus has two products that it says address 85% of the causes of female infertility, and assist in earlier diagnosis and treatment: the OvuSense home-use ovulation detection and fertile period predictor and the FertiloScope, a trans-vaginal laparoscopic instrument that is designed to diagnose and treat the main physical causes of female infertility in one minimally invasive outpatient procedure.

Josh tag:typepad.com,2003:post-6a00d83452f00669e2017eeb34d364970d 2013-05-15T17:34:15-04:00 2013-05-15T17:34:53-04:00

Once beyond reproach, knee replacement surgeries are getting a long, hard look by surgeons, researchers, and companies trying to determine whether success rates that exceed 90% can be improved upon by using customized implants or surgical robots.

Josh tag:typepad.com,2003:post-6a00d83452f00669e201901c2c03cc970b 2013-05-14T14:13:52-04:00 2013-05-14T14:13:52-04:00

An unprecedented release of data by the agency highlights vast differences across the country between what hospitals charge for different procedures, but the disparities by and large don’t reflect actual hospital costs.

Josh tag:typepad.com,2003:post-6a00d83452f00669e2019101e71ff9970c 2013-05-08T15:22:28-04:00 2013-05-08T15:25:11-04:00

Although Edwards is the pioneer and market leader in TAVR, there is no shortage of competitors – in both the aortic and mitral valve segments – developing next-generation devices who would be happy with a fraction of this potential multibillion-dollar opportunity.

Josh tag:typepad.com,2003:post-6a00d83452f00669e201901bf0f7fd970b 2013-05-08T15:09:36-04:00 2013-05-08T15:10:18-04:00

Call it digital health, mobile health, connected health, or information-enabled care delivery, in health care there is a new convergence of wireless sensing technologies, tablets, personalized medicine, cloud-based computing, and novel business models, and it all goes under the rubric of health care efficiency. Going forward, the latter will be the driver of Aberdare Venture Capital’s investment strategy, and in April, the VC made an announcement that signaled its whole-hearted commitment to the space.

Josh